| Serial Number | 98050125 |
| Word Mark | OPIS |
| Filing Date | Tuesday, June 20, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Friday, June 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Help in the management of business affairs or commercial functions of an industrial or commercial enterprise; analysis of market studies; analysis of market research statistics; market research and analysis; statistical analysis and reporting services for business purposes; business advice and consultancy; compilation of statistics; computerized data processing; electronic data processing; providing of commercial statistical information in the medical field; business management of hospitals; maintaining personal medical history records and files; maintaining files and records concerning the medical condition of individuals; marketing studies; preparation of market reports and studies; collating of data in computer databases in the nature of analyzing and compiling business data; conducting business and market research surveys; administrative management of health care clinics; compilation of statistics relating to health care utilization for business or commercial purposes; data processing services in the field of healthcare; data processing services in the nature of automated processing of medical data; management and compilation of computerized databases; compilation of information into computer databases; advertising services to promote public awareness of medical issues |
| Translation of Words in Mark | The English translation of "OPIS" in the mark is "DESCRIPTION". |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biological and medical research; biochemistry research services; biotechnology research; pharmaceutical research; laboratory research in the field of pharmaceuticals; biological research; medical research; scientific research; bacteriological research and analysis; bacteriological research and testing; research and development services relating to vaccines and medicines; pharmaceutical research and development; scientific and medical research and development; medical and scientific research in the field of pharmacogenetics; biological research and analysis; chemical research and analysis; scientific research and analysis; chemical research; medical research laboratory services; laboratory research and analysis in the fields of pharmaceuticals and biotechnology; consultancy and laboratory research in the field of bacteriology; research and development services in the field of biochemistry; research and development services in the field of pharmaceutical preparations; research in the field of artificial intelligence technology; scientific research in the field of genetics and genetic engineering; research and development of vaccines; preparation of scientific reports relating to scientific research; pharmaceutical drug development services; drug discovery services; scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical drugs; product design and development in the field of medical technology; providing medical and scientific information about the results of clinical trials in the field of pharmaceuticals; design and development of computer software for database management and data processing in the field of medical technology; testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and testing of new products for others; pharmaceutical testing |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 23, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 23, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OPIS SRL |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Desio 20832 IT |
| Event Date | Event Description |
| Friday, June 23, 2023 | NEW APPLICATION ENTERED |
| Sunday, July 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 28, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 28, 2024 | LETTER OF SUSPENSION E-MAILED |
| Friday, June 28, 2024 | SUSPENSION LETTER WRITTEN |
| Friday, June 28, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |